Cargando…

Imaging of hypoxia in human glioblastoma with dynamic 18F-fluoromisonidazole PET

Aim: The purpose of this study was to locate the levels of hypoxia in glioblastoma PET images measured with 18F-fluoromisonidazole in human subjects. It is recognized that tumors with hypoxia are resistant to treatment by radiotherapy and chemotherapy. Methods: The images were acquired in dynamic mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abdo, Redha-Alla, Lamare, Frédéric, Fernandez, Philippe, Bentourkia, M’hamed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	OAE Publishing Inc. 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019176/ https://www.ncbi.nlm.nih.gov/pubmed/35582145 http://dx.doi.org/10.20517/cdr.2018.21

Ejemplares similares

(18)F-Fluoromisonidazole in tumor hypoxia imaging
por: Xu, Zuoyu, et al.
Publicado: (2017)

[(18)F]Fluoromisonidazole PET in rectal cancer
por: Puri, Tanuj, et al.
Publicado: (2017)

Evaluation of hypoxia in an experimental rat tumour model by [(18)F]Fluoromisonidazole PET and immunohistochemistry
por: Dubois, L, et al.
Publicado: (2004)

A Comparative Study of Noninvasive Hypoxia Imaging with (18)F-Fluoroerythronitroimidazole and (18)F-Fluoromisonidazole PET/CT in Patients with Lung Cancer
por: Wei, Yuchun, et al.
Publicado: (2016)

Regional (18)F-fluoromisonidazole PET images generated from multiple advanced MR images using neural networks in glioblastoma
por: Qin, Jianhua, et al.
Publicado: (2022)

Monitoring vascular normalization induced by antiangiogenic treatment with 18F‐fluoromisonidazole‐PET
por: Hernández-Agudo, Elena, et al.
Publicado: (2015)

Timing of hypoxia PET/CT imaging after 18F-fluoromisonidazole injection in non-small cell lung cancer patients
por: Bourigault, Pauline, et al.
Publicado: (2022)

Quantitative evaluation of oxygen metabolism in the intratumoral hypoxia: (18)F-fluoromisonidazole and (15)O-labelled gases inhalation PET
por: Watabe, Tadashi, et al.
Publicado: (2017)

In vivo evaluation of percutaneous carbon dioxide treatment for improving intratumoral hypoxia using (18)F-fluoromisonidazole PET-CT
por: Maruyama, Koji, et al.
Publicado: (2021)

The Roles of Hypoxia Imaging Using (18)F-Fluoromisonidazole Positron Emission Tomography in Glioma Treatment
por: Hirata, Kenji, et al.
Publicado: (2019)

Kinetic analysis of dynamic (18)F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer
por: Thorwarth, Daniela, et al.
Publicado: (2005)

Evaluation of tumor hypoxia prior to radiotherapy in intermediate-risk prostate cancer using (18)F-fluoromisonidazole PET/CT: a pilot study
por: Supiot, Stéphane, et al.
Publicado: (2018)

Radiation treatment monitoring using multimodal functional imaging: PET/CT ((18)F-Fluoromisonidazole & (18)F-Fluorocholine) and DCE-US
por: Arteaga-Marrero, Natalia, et al.
Publicado: (2015)

Erratum to: Radiation treatment monitoring using multimodal functional imaging: PET/CT ((18)F-Fluoromisonidazole & (18)F-Fluorocholine) and DCE-US
por: Arteaga-Marrero, Natalia, et al.
Publicado: (2016)

(18)F-fluoromisonidazole predicts evofosfamide uptake in pancreatic tumor model
por: Grkovski, Milan, et al.
Publicado: (2018)

A prospective clinical trial of tumor hypoxia imaging with (18)F-fluoromisonidazole positron emission tomography and computed tomography (F-MISO PET/CT) before and during radiation therapy
por: Tachibana, Izumi, et al.
Publicado: (2013)

Assessing Biological Response to Bevacizumab Using 18F-Fluoromisonidazole PET/MR Imaging in a Patient with Recurrent Anaplastic Astrocytoma
por: Barajas, Ramon F., et al.
Publicado: (2015)

Evaluation of changes in the tumor microenvironment after sorafenib therapy by sequential histology and (18)F-fluoromisonidazole hypoxia imaging in renal cell carcinoma
por: MURAKAMI, MASAHIRO, et al.
Publicado: (2012)

Change in (18)F-Fluoromisonidazole PET Is an Early Predictor of the Prognosis in the Patients with Recurrent High-Grade Glioma Receiving Bevacizumab Treatment
por: Yamaguchi, Shigeru, et al.
Publicado: (2016)

Biological characteristics of intratumoral [F-18]-fluoromisonidazole distribution in a rodent model of glioma
por: HATANO, TOSHIYUKI, et al.
Publicado: (2013)

Reproducibility of (18)F-fluoromisonidazole intratumour distribution in non-small cell lung cancer
por: Grkovski, Milan, et al.
Publicado: (2016)

Correlation of Tumor Hypoxia Metrics Derived from (18)F-Fluoromisonidazole Positron Emission Tomography and Pimonidazole Fluorescence Images of Optically Cleared Brain Tissue
por: Scarpelli, Matthew L., et al.
Publicado: (2020)

(18)F‐fluoromisonidazole uptake in advanced stage non‐small cell lung cancer: A voxel‐by‐voxel PET kinetics study
por: McGowan, Daniel R., et al.
Publicado: (2017)

Intracellular hypoxia measured by (18)F-fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen receptor-positive breast cancer
por: Asano, Aya, et al.
Publicado: (2018)

Whole tumor kinetics analysis of (18)F-fluoromisonidazole dynamic PET scans of non-small cell lung cancer patients, and correlations with perfusion CT blood flow
por: McGowan, Daniel R., et al.
Publicado: (2018)

Evaluating cardiac hypoxia in hibernating myocardium: Comparison of (99m)Tc-MIBI/(18)F-fluorodeoxyglucose and (18)F-fluoromisonidazole positron emission tomography-computed tomography in relation to normal, hibernating, and infarct myocardium
por: Jagtap, Rajlaxmi, et al.
Publicado: (2019)

Simultaneous Mapping of Vasculature, Hypoxia, and Proliferation Using Dynamic Susceptibility Contrast MRI, (18)F-FMISO PET, and (18)F-FLT PET in Relation to Contrast Enhancement in Newly Diagnosed Glioblastoma
por: Collet, Solène, et al.
Publicado: (2021)

Evaluation of isocitrate dehydrogenase mutation in 2021 world health organization classification grade 3 and 4 glioma adult-type diffuse gliomas with 18F-fluoromisonidazole PET
por: Wang, Yang, et al.
Publicado: (2023)

Correction to: Intracellular hypoxia measured by F-18 fluoromisonidazole positron emission tomography has prognostic impact in patients with estrogen-receptor positive breast (BRCR-D17-00693)
por: Asano, Aya, et al.
Publicado: (2018)

First Comparison between [18f]-FMISO and [18f]-Faza for Preoperative Pet Imaging of Hypoxia in Lung Cancer
por: Thureau, Sébastien, et al.
Publicado: (2021)

Reproducibility of 18F-fluoromisonidazole intratumour distribution in non-small cell lung cancer; methodological issues to avoid mismanagement of the patients
por: Sabour, Siamak
Publicado: (2017)

[(18)F] fluoromisonidazole and [(18)F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study
por: Gagel, Bernd, et al.
Publicado: (2006)

Kinetic Evaluation of the Hypoxia Radiotracers [(18)F]FMISO and [(18)F]FAZA in Dogs with Spontaneous Tumors Using Dynamic PET/CT Imaging
por: Choen, Sangkyung, et al.
Publicado: (2022)

Intratumoral Injection of Anlotinib Hydrogel Combined With Radiotherapy Reduces Hypoxia in Lewis Lung Carcinoma Xenografts: Assessment by Micro Fluorine-18-fluoromisonidazole Positron Emission Tomography/Computed Tomography Hypoxia Imaging
por: Gao, Qin, et al.
Publicado: (2021)

pO polarography, contrast enhanced color duplex sonography (CDS), [(18)F] fluoromisonidazole and [(18)F] fluorodeoxyglucose positron emission tomography: validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the puzzle of tumor hypoxia?
por: Gagel, Bernd, et al.
Publicado: (2007)

Multiparametric [(18)F]Fluorodeoxyglucose/ [(18)F]Fluoromisonidazole Positron Emission Tomography/ Magnetic Resonance Imaging of Locally Advanced Cervical Cancer for the Non-Invasive Detection of Tumor Heterogeneity: A Pilot Study
por: Pinker, Katja, et al.
Publicado: (2016)

A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using (18)F-FMISO-PET
por: Rockne, Russell C., et al.
Publicado: (2015)

Assessment of tumor hypoxia and perfusion in recurrent glioblastoma following bevacizumab failure using MRI and (18)F-FMISO PET
por: Huang, Shiliang, et al.
Publicado: (2021)

Hypoxia PET Imaging with [18F]-HX4—A Promising Next-Generation Tracer
por: Sanduleanu, Sebastian, et al.
Publicado: (2020)

Hypoxia is important in F-18 FDG accumulation in thecoma-fibroma tumors on F-18 FDG PET/CT scans
por: SEINO, HIROKO, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_a8u9odptnl0pu4hc4p6p94lf0d